Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aida Santa Olalla"'
Autor:
Mieke Van Hemelrijck, Chris Brew-Graves, Neil McCartan, Louise Brown, Manuel Rodriguez-Justo, Aiman Haider, Alex Freeman, Mark Emberton, Kingshuk Pal, William Maynard, Aida Santaolalla, Nora Pashayan, Malcolm Mason, Tom Syer, Chris Parker, Caroline M Moore, Charlotte Bevan, Jayshireen Singh, Stuart Mackay-Thomas, Kate Walters, Mehul Mathukia, Charlotte Moss, David Sharpe, Kinnari Naik, Thomas Callender, Andrew Feber, Lee Berney, Anwar Padhani, Shonit Punwani, Hashim U Ahmed, Richard Kaplan, Teresa Marsden, Joanna Hadley, Steve Tuck, Saran Green, Ton Coolen, Elizabeth Isaac, Giorgio Brembilla, Douglas Kopcke, Francesco Giganti, Gerhardt Attard, Hina Pervez, Eric Aboagye, Elena Frangou, Fiona Gong, Louise C Brown, Aida Santa Olalla, Rosie Clow, Ged Corbett, Anna Wingate, Fatima Akbar, Suparna Thakali, Ashling Henderson, Dizem Tekin, Joey Clement, Harbit Sidhu, Teresita Beeston, Katerina Soteriou, Francesca Rawlins, Pirruntha Sivaharan, Savahnna Wolfe, Henry Tam, Heather Bholastewart, Sarp Keskin, Mariana Bertoncelli, Paul Boutros, Hayley Whitaker, Caroline Dive, Eytan Domany, Peter Parker, Andrew Prugia, Claire Chalmers-Watson, Alexander Gilkes, Dr Hira
Publikováno v:
BMJ Oncology, Vol 2, Iss 1 (2023)
Objective In men with a raised prostate-specific antigen (PSA), MRI increases the detection of clinically significant cancer and reduces overdiagnosis, with fewer biopsies. MRI as a screening tool has not been assessed independently of PSA in a forma
Externí odkaz:
https://doaj.org/article/9e67b1d6c59a4ab9a2b0588957b411c1
Autor:
Danielle Crawley, Ashish Chandra, Massimo Loda, Cheryl Gillett, Paul Cathcart, Ben Challacombe, Gary Cook, Declan Cahill, Aida Santa Olalla, Fidelma Cahill, Gincy George, Sarah Rudman, Mieke Van Hemelrijck
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-12 (2017)
Abstract Background Metformin is a biguanide oral hypoglycaemic agent commonly used for the treatment of type 2 diabetes mellitus. In addition to its anti-diabetic effect, metformin has also been associated with a reduced risk of cancer incidence of
Externí odkaz:
https://doaj.org/article/82f907164cb743dda31b3eea88380ee6
Autor:
Kerri Beckmann, Chris Bangma, Jozien Hellman, Aida Santa Olalla, Daan Nieboer, Anders Bjartell, Peter Carroll, Todd Morgan, Bruce Trock, Riccardo Valdagni, Monique Roobol, null for Movember Foundation's GAP3 Consortium
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Despite active surveillance (AS) being the preferred management option for low-risk prostate cancer (PCa), formal guidelines on optimal follow-up are inconsistent and pra...
Autor:
Mieke Van Hemelrijck, Xi Ji, Jozien Helleman, Monique J. Roobol, Wim van der Linden, Daan Nieboer, Chris H. Bangma, Mark Frydenberg, Antti Rannikko, Lui S. Lee, Vincent J. Gnanapragasam, Mike W. Kattan, Bruce Trock, Behfar Ehdaie, Peter Carroll, Christopher Filson, Jeri Kim, Christopher Logothetis, Todd Morgan, Laurence Klotz, Tom Pickles, Eric Hyndman, Caroline M. Moore, Vincent Gnanapragasam, Prokar Dasgupta, Chris Bangma, Monique Roobol, Arnauld Villers, Riccardo Valdagni, Antoinette Perry, Jonas Hugosson, Jose Rubio-Briones, Anders Bjartell, Lukas Hefermehl, Lee Lui Shiong, Yoshiyuki Kakehi, Byung Ha Chung, Theo van der Kwast, Henk Obbink, Tim Hulsen, Cees de Jonge, Mike Kattan, Ji Xinge, Kenneth Muir, Artitaya Lophatananon, Michael Fahey, Ewout Steyerberg, Liying Zhang, Aida Santa Olalla, Kerri Beckmann, Brian Denton, Andrew Hayen, Paul Boutros, Wei Guo, Nicole Benfante, Janet Cowan, Dattatraya Patil, Emily Tolosa, Tae-Kyung Kim, Alexandre Mamedov, Vincent La Pointe, Trafford Crump, Jenna Kimberly-Duffell, Aida Santaolalla, Jonathan Olivier, Tiziana Rancati, Helén Ahlgren, Juanma Mascarós, Annica Löfgren, Kurt Lehmann, Catherine Han Lin, Hiromi Hirama, Kwang Suk Lee, Guido Jenster, Anssi Auvinen, Masoom Haider, Kees van Bochove, Ballentine Carter, Sam Gledhill, Mark Buzza, Sophie Bruinsma
Publikováno v:
Van Hemelrijck, M, Ji, X, Helleman, J, Roobol, M J, van der Linden, W, Nieboer, D, Bangma, C H, Frydenberg, M, Rannikko, A, Lee, L S, Gnanapragasam, V J, Kattan, M W & Santaolalla, A 2018, ' Reasons for discontinuing active surveillance : Assessment of 21 centres in 12 countries in the Movember GAP3 Consortium ', European Urology . https://doi.org/10.1016/j.eururo.2018.10.025
Eur Urol
European Urology, 75(3), 523-531. Elsevier
Eur Urol
European Urology, 75(3), 523-531. Elsevier
Background: Careful assessment of the reasons for discontinuation of active surveillance (AS) is required for men with prostate cancer (PCa). Objective: Using Movember's Global Action Plan Prostate Cancer Active Surveillance initiative (GAP3) databas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::591760405c18d0da0116eefeb5d9974e
https://kclpure.kcl.ac.uk/ws/files/102326239/Reasons_for_discontinuing_active_VAN_HEMELRIJICK_Accepted13October2018_GREEN_AAM.pdf
https://kclpure.kcl.ac.uk/ws/files/102326239/Reasons_for_discontinuing_active_VAN_HEMELRIJICK_Accepted13October2018_GREEN_AAM.pdf
Publikováno v:
Clinical Trials Week; 6/10/2024, p1581-1581, 1p